Other Cancers Efficacy and Safety of Ixazomib and Daratumumab without Dexamethasone (I-DARA) in Elderly Frail RRMM Patients Jul 28, 2023
Gastrointestinal Cancer Adjuvant Immunotherapy in Resected GEA with High Recurrence Risk Jul 27, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tumor Growth Inhibition-OS Model: Alectinib Data Validation Jul 27, 2023
Lymphoma,Other Cancers Pembrolizumab as First Treatment for CHL in Older or ABVD-Ineligible Patients Jul 27, 2023
